Alyeska Group holds 3.05M Bakkt shares; 9.99% cap (BKKT)
Rhea-AI Filing Summary
Bakkt, Inc. ownership disclosure: Alyeska Investment Group and affiliated persons beneficially own 3,053,153 shares of Class A common stock, representing 9.99% of the class as of March 31, 2026. The position comprises 1,023,810 currently held shares and 2,029,343 shares issuable upon exercise of pre-funded warrants constrained by a 9.99% beneficial ownership limitation. The filing cites 30,562,096 shares outstanding per the Form 10-K dated March 19, 2026. The filing states Alyeska Investment Group exercises voting and investment control for Alyeska Master Fund, L.P., and that Anand Parekh may be deemed a beneficial owner (with a disclaimer).
Positive
- None.
Negative
- None.
Insights
Disclosure explains beneficial ownership, warrant limits, and control relationships.
The statement details a 9.99% beneficial ownership position comprised of direct shares and exercisable pre-funded warrants, and explicitly preserves the beneficial ownership limitation that caps exercise. The filing cites March 19, 2026 for the 30,562,096 share outstanding base.
Key legal points: the 9.99% limitation is a contractual/plan constraint that affects exercisability; attribution language and the joint filing statement follow Rule 13d conventions. Future filings will clarify any exercise activity or changes in ownership.
Position is large but capped; control and attribution are disclosed.
The report shows shared voting and dispositive power over 3,053,153 shares via Alyeska entities and notes that Alyeska Investment Group acts as investment manager for Alyeska Master Fund, L.P. The filing includes an explicit disclaimer by Mr. Parekh.
Practical implications: exercise of additional warrant shares is limited by the 9.99% cap, so near-term dilution from these warrants depends on outstanding share count and any changes to that count.
Key Figures
Key Terms
pre-funded warrants financial
beneficial ownership limitation regulatory
Rule 13d-1(k) regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.